Annual Incidence of First Silent Stroke in the United States: A Preliminary Estimate

Introduction: Current incidence estimates of in-hospital cardiac arrest in the United States are based on data from more than a decade ago, with an estimated 200,000 adult cases per year. The aim of this study was to estimate the contemporary incidence of in-hospital cardiac arrest in adult patients, which may better inform the public health impact of in-hospital cardiac arrest in the United States. Methods: Using the Get With The Guidelines®-Resuscitation (GWTG-R) registry, we developed a negative binomial regression model to estimate the incidence of index in-hospital cardiac arrests in adult patients (>18 years) between 2008 and 2016 based on hospital-level characteristics. The model coefficients were then applied to all United States hospitals, using data from the American Hospital Association Annual Survey, to obtain national incidence estimates. Hospitals only providing care to pediatric patients were excluded from the analysis. Additional analyses were performed including both index and recurrent events. Results: There were 154,421 index cardiac arrests from 388 hospitals registered in the GWTG-R registry. A total of 6,808 hospitals were available in the American Hospital Association database, of which 6,285 hospitals provided care to adult patients. The average annual incidence was estimated to be 283,700 in-hospital cardiac arrests. When including both index and recurrent cardiac arrests, the average annual incidence was estimated to 344,800 cases. Conclusions: Our analysis indicates that there are approximately 280,000 adult patients with in-hospital cardiac arrests per year in the United States. This estimate provides the contemporary annual incidence of the burden from in-hospital cardiac arrest in the United States.

Download Full-text

Childhood cardiomyopathy

ESC CardioMed ◽

10.1093/med/9780198784906.003.0799_update_001 ◽

2018 ◽

pp. 1554-1560

Author(s):

Juan Pablo Kaski ◽

Gabrielle Norrish

Keyword(s):

United States ◽

Hypertrophic Cardiomyopathy ◽

Dilated Cardiomyopathy ◽

Restrictive Cardiomyopathy ◽

The United States ◽

Epidemiological Studies ◽

Common Type ◽

Annual Incidence ◽

True Prevalence

Cardiomyopathy in childhood is a rare and heterogeneous disease. The true prevalence is unknown; however, epidemiological studies from the United States, Australia, and Finland have reported an annual incidence of between 0.65 and 12.4 per 100,000. The most common type of cardiomyopathy in childhood is dilated cardiomyopathy followed by hypertrophic cardiomyopathy, while restrictive cardiomyopathy and other forms are much rarer (58.6% vs 25.5% vs 2.5% respectively). Although children may present at any age, the majority present under 1 year of age (63.4%).

Download Full-text

Prion disease incidence in the United States: 2003–2015

Neurology ◽

10.1212/wnl.0000000000008680 ◽

2019 ◽

Vol 94 (2) ◽

pp. e153-e157 ◽

Cited By ~ 2

Author(s):

Ryan A. Maddox ◽

Marissa K. Person ◽

Janis E. Blevins ◽

Joseph Y. Abrams ◽

Brian S. Appleby ◽

...

Keyword(s):

United States ◽

Cause Of Death ◽

Prion Disease ◽

Disease Incidence ◽

The United States ◽

Annual Incidence ◽

Mortality Data ◽

Genetic Test Results ◽

Average Annual Incidence ◽

Death Data

ObjectiveTo report the incidence of prion disease in the United States.MethodsPrion disease decedents were retrospectively identified from the US national multiple cause-of-death data for 2003–2015 and matched with decedents in the National Prion Disease Pathology Surveillance Center (NPDPSC) database through comparison of demographic variables. NPDPSC decedents with neuropathologic or genetic test results positive for prion disease for whom no match was found in the multiple cause-of-death data were added as cases for incidence calculations; those with cause-of-death data indicating prion disease but with negative neuropathology results were removed. Age-specific and age-adjusted average annual incidence rates were then calculated.ResultsA total of 5,212 decedents were identified as having prion disease, for an age-adjusted average annual incidence of 1.2 cases per million population (range 1.0 per million [2004 and 2006] to 1.4 per million [2013]). The median age at death was 67 years. Ten decedents were <30 years of age (average annual incidence of 6.2 per billion); only 2 of these very young cases were sporadic forms of prion disease. Average annual incidence among those ≥65 years of age was 5.9 per million.ConclusionsPrion disease incidence can be estimated by augmenting mortality data with the results of neuropathologic and genetic testing. Cases <30 years of age were extremely rare, and most could be attributed to exogenous factors or the presence of a genetic mutation. Continued vigilance for prion diseases in all age groups remains prudent.

Download Full-text

A Preliminary Estimate of the Total Impact of Ozone and PM2.5 Air Pollution on Premature Mortalities in the United States

Air Pollution Modeling and Its Application XVII ◽

10.1007/978-0-387-68854-1_12 ◽

2007 ◽

pp. 102-108

Author(s):

D. L. Mauzerall ◽

Q. Tong

Keyword(s):

United States ◽

Air Pollution ◽

The United States ◽

Preliminary Estimate ◽

Total Impact

Download Full-text

Burden and future projection of revision Total hip Arthroplasty in South Korea

BMC Musculoskeletal Disorders ◽

10.1186/s12891-021-04235-3 ◽

2021 ◽

Vol 22 (1) ◽

Author(s):

Jung-Wee Park ◽

Seok-Hyung Won ◽

Sun-Young Moon ◽

Young-Kyun Lee ◽

Yong-Chan Ha ◽

...

Keyword(s):

United States ◽

South Korea ◽

East Asia ◽

The United States ◽

Annual Incidence ◽

Future Projection ◽

Revision Thas ◽

Revision Tha ◽

Future Burden ◽

Hip Arthroplasties

Abstract Background The annual number of hip arthroplasties is increasing combined with the aging population worldwide. In accordance with the increasing number of primary hip arthroplasties, the number of revision total hip arthroplasties (THAs) is expected to increase. The incidence and burden of revision THAs in the United States and have been reported by registry studies. To identify potential differences according to ethnics and regional practice, it is important to obtain data from East Asia. Nevertheless, there has been a lack of studies on the burden and future projection of revision THA based on a large-scale database in East Asia. The purpose of this study was to evaluate annual incidence and burden of revision THAs and to project the future burden in South Korea. Methods We identified primary THAs, primary hemiarthroplasties (HAs) and revision THAs, which were performed from 2010 to 2018, using database of Health Insurance and Review and Assessment (HIRA); nation-wide medical claim system of South Korea. The annual incidence rates (per 100,000) of primary THA, primary HA and revision THA, and the annual burden of revision THA; the number of revision THAs divided by the sum of primary hip arthroplasties and revision THAs, were calculated. The future burden of revision THAs were projected through 2030 using generalized linear model with Quasi-poisson regression. Results During the 9-year period, the annual incidences of primary THA, primary HA and revision THA increased by 47, 29 and 3%, respectively, while the revision burden decreased from 0.13 to 0.10. Compared to 2018, the annual incidences of primary THA, HA, and revision THA were projected to increase by 7.2, 2.3 and 1.1% per year, respectively, whereas the burden of revision THA was projected to decrease to 0.07 in 2030. Conclusion Trends of revision THA in South Korea were similar with those of national registry studies from the United States. The annual incidence of revision THA has steadily increased, whereas its burden has decreased. Findings of our study could be used for epidemiological comparison between Western countries and East Asia as well as for the establishment of medical policies of revision THA in East Asian countries.

Download Full-text

Out of Hospital Pediatric Cardiac Arrest

Journal of Pediatrics & Neonatal Biology ◽

10.33140/jpnb.02.01.09 ◽

2018 ◽

Vol 2 (1) ◽

Keyword(s):

United States ◽

Overall Survival ◽

Cardiac Arrest ◽

Sudden Cardiac Arrest ◽

The United States ◽

Annual Incidence ◽

International Data ◽

Therapeutic Tools ◽

Hospital Pediatric ◽

Hospital Cardiac Arrest

Out of hospital cardiac arrest in the pediatric patient is an uncommon event [1]. Exact incidence of occurrence in the United States is difficult to determine as epidemiologic reporting is not nationally mandated. Previous data has suggested an annual incidence of 0.8- 6.0 per 100,000 patients [2]. International data has helped answer this question suggesting the annual incidence of pediatric sudden cardiac arrest of 0.23 percent [3]. Out of hospital cardiac arrest can be due to a variety of insults and accordingly, outcomes vary depending upon the initial insult. Overall survival in children aged 0-17 years old is approximately 7.2 percent [1] to 8.3 percent [4]. The purpose of this article is to review present therapeutic tools and recommendations available to the healthcare provider.

Download Full-text

Lichen planopilaris: Annual incidence in four hair referral centers in the United States

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2007.11.007 ◽

2008 ◽

Vol 58 (2) ◽

pp. 352-353 ◽

Cited By ~ 19

Author(s):

Blanca E. Ochoa ◽

Lloyd E. King ◽

Vera H. Price

Keyword(s):

United States ◽

The United States ◽

Annual Incidence ◽

Lichen Planopilaris

Download Full-text

Childhood cardiomyopathy

ESC CardioMed ◽

10.1093/med/9780198784906.003.0799 ◽

2018 ◽

pp. 1554-1560

Author(s):

Juan Kaski ◽

Gabrielle Norrish

Keyword(s):

United States ◽

Hypertrophic Cardiomyopathy ◽

Dilated Cardiomyopathy ◽

Restrictive Cardiomyopathy ◽

The United States ◽

Epidemiological Studies ◽

Common Type ◽

Annual Incidence ◽

True Prevalence

Cardiomyopathy in childhood is a rare and heterogeneous disease. The true prevalence is unknown; however, epidemiological studies from the United States, Australia, and Finland have reported an annual incidence of between 0.65 and 12.4 per 100,000. The most common type of cardiomyopathy in childhood is dilated cardiomyopathy followed by hypertrophic cardiomyopathy, while restrictive cardiomyopathy and other forms are much rarer (58.6% vs 25.5% vs 2.5% respectively). Although children may present at any age, the majority present under 1 year of age (63.4%).

Download Full-text